Latest news

PrimaryBid.com Offer

25 June 2019

Placing to Progress TYK2/JAK1 Programmes

25 June 2019

Portfolio Update

13 June 2019

Key Takeaways from SRA737 Webcast at ASCO

03 June 2019

Find out more

Partners

Sareum actively seeks collaboration partners for its research programmes.

Find out more large-arrow.png

Pipeline

Sareum has an innovative pipeline of drug development candidates.

Find out more large-arrow.png

Investors small-arrow.png

Presentationssmall-arrow.png

BioTrinity, April 2019 (Slides)
Proactive Investors, March 2019 (Video)

Share price and RNS

Share price data
Regulatory News Service (RNS)

 

  • @Sareumplc Latest tweet

    RT @JebKeiper: Tyk2 is what this is all about $BMY. Game changing new MOA: the tykinibs are reshaping immunology, first by upending the pso… via @Sareumplc
    View more

Contact

Sareum Limited
Unit 2A, Langford Arch
London Road, Pampisford
Cambridge CB22 3FX
United Kingdom


tel: +44 (0) 1223 497700
fax: +44 (0) 1223 497701
email_white.png

Downloads

Yearly Results 2018     Notice of AGM 2018

Annual Report 2018  AGM Votes 2018    

Results 2018  Annual Report 2018